Trending News Today: ICER Recommends Lower Price for MS Drug Siponimod

The Institute for Clinical and Economic Review (ICER) recommended that Novartis lower the price of its multiple sclerosis (MS) drug siponimod (Mayzent), Reuters reported. According to the article, ICER described the list price, which is $88,561, as “far out of line” compared with its benefits for patients. However, Novartis disputed the findings, saying that the feedback and recommendations it gave to ICER were not taken into account and that the group did not use the right comparisons to establish cost effectiveness, the article reported.
A new study suggests that patients with pediatric-onset multiple sclerosis (MS) face greater cognitive decline than patients who experience onset as adults, MD Magazine reported. According to the article, the researchers analyzed data from the Swedish MS Registry from April to August 2018 to compare levels of cognitive decline between patients with pediatric-onset MS and those with adult-onset disease. Overall, many of the younger patients appeared mostly stable, only to decline sharply within 5 years of follow-up or fail to acquire age-appropriate gains relative to their peers, the article reported.
On Friday, the Department of Health and Human Services sent to the White House for review a proposal to lower certain drugs in Medicare by linking them to lower prices paid in other countries, The Hill reported. According to the article, President Trump previously proposed the idea in October, but it was in the early stages of the regulatory process at the time. The move to send the proposal to the White House for review indicates that the idea is moving forward, but it is unknown how long the process of the review will take, the article reported

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.